- Available Technology
This biosensor provides a means for rapid, sensitive, and specific detection of bacterial strains at the point of care. It is capable of detecting pathogenic bacteria through an impedance method by tracking the phase and magnitude response from a generated sinusoidal signal. Current approaches to infection assessment rely on imaging technologies or swab cultures, which are effective but expensive in time and personnel costs. Additionally, assessment in a clinical setting is subjective and highly based on skill level of the clinician. This creates the need to develop a technology that facilitates improving patient outcomes and limiting medical costs. The global biosensors market is expected to reach $36 million by 2027, growing at a CAGR of 7.9%. In this high demand market environment, Clemson University researchers have created a method to produce nanofiber-based impedance and electrochemical biosensors that can be tuned to specific bacterial species and quantification that can be accomplished to provide information about current state as well as growth rate.
Biosensor, Wound healing
This technology includes a method to produce nanofiber-based impedance and electrochemical biosensors. It is capable of producing biosensors that can detect pyocyanin from pseudomonas aeruginosa, potassium ferricyanide, and methylene blue. Solution blow spinning of nanofibers is used to develop conductive electrical nanofibers and provide dielectric substrate for the biosensor electrodes. Carbon nanotubes have been used as a conductive filler material to generate conductive nanofiber mats.
Stay up-to-date with the latest trends in the innovation and research industry. Sign up for our newsletter to see how CURF is making a difference and impacting the economy where we live.